文献速递肝病消化道肿瘤与早癌

患者自述障碍与肝硬化患者接受肝细胞癌监测相关:多中心队列研究

Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-07-03

该研究对3个健康系统2871例肝硬化患者进行电话调查,1020例(35.5%)完成。近半数报告监测障碍,包括费用(28.9%)、预约困难(24.1%)和交通(17.8%)。半年度监测与接受肝病专科诊疗显著相关(OR 30.1),与患者报告障碍负相关(OR 0.62)。

要点

  • 近半数肝硬化患者报告肝细胞癌监测障碍,包括费用、预约困难和交通问题。
  • 接受肝病专科诊疗与半年度监测强烈相关(OR 30.1,95%CI 17.5-51.8)。
  • 患者报告障碍与半年度监测负相关(OR 0.62,95%CI 0.41-0.94)。

核心结论

  • 患者报告的知识缺陷、费用、预约困难和交通等障碍与肝细胞癌监测接受频率较低显著相关,提示需要以患者为中心的干预措施,如患者导航。

研究设计与样本

  • 多中心队列研究,来自3个健康系统(三级转诊中心、安全网健康系统和退伍军人事务部)的2871例肝硬化患者受邀,1020例(35.5%)完成电话调查。

主要发现

  • 1020例完成调查的患者对肝细胞癌发生高度关注且知识水平高,但存在知识缺陷,如认为体检和实验室结果正常时监测不必要。
  • 近半数患者报告监测障碍,包括费用(28.9%)、预约困难(24.1%)和交通(17.8%)。
  • 调查前一年内,745例(73.1%)接受至少1次监测检查;281例接受按计划的半年度监测,464例接受年度监测。
  • 半年度监测( vs 无)与接受肝病专科诊疗显著相关(OR 30.1;95%CI 17.5-51.8),与患者报告障碍负相关(OR 0.62;95%CI 0.41-0.94)。
  • 年度监测 vs 无监测的关联模式相似,但效应量减小。

临床怎么用

  • 原文结论认为需要以患者为中心的干预措施,如患者导航,但未给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than 20% of patients with cirrhosis do not receive semi-annual hepatocellular carcinoma (HCC) surveillance as recommended. Few studies have evaluated the effects of patient-level factors on surveillance receipt. METHODS: We administered a telephone survey to a large cohort of patients with cirrhosis from 3 health systems (a tertiary care referral center, a safety-net health system, and Veterans Affairs) to characterize patient knowledge, attitudes, and perceived barriers of HCC surveillance. Multinomial logistic regression was performed to identify factors associated with HCC surveillance receipt (semi-annual and annual vs none) during the 12-month period preceding survey administration. RESULTS: Of 2871 patients approached, 1020 (35.5%) completed the survey. Patients had high levels of concern about developing HCC and high levels of knowledge about HCC. However, patients had knowledge deficits, including believing surveillance was unnecessary when physical examination and laboratory results were normal. Nearly half of patients reported barriers to surveillance, including costs (28.9%), difficulty scheduling (24.1%), and transportation (17.8%). In the year before the survey, 745 patients (73.1%) received 1 or more surveillance examination; 281 received on-schedule, semi-annual surveillance and 464 received annual surveillance. Semi-annual HCC surveillance (vs none) was significantly associated with receipt of hepatology subspecialty care (odds ratio, 30.1; 95% CI, 17.5-51.8) and inversely associated with patient-reported barriers (odds ratio, 0.62; 95% CI, 0.41-0.94). Patterns of associations comparing annual vs no surveillance were similar although the magnitude of effects were reduced. CONCLUSIONS: Patient-reported barriers such as knowledge deficits, costs, difficulty scheduling, and transportation are significantly associated with less frequent receipt of HCC surveillance, indicating a need for patient-centered interventions, such as patient navigation.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Singal AG, Tiro JA, Murphy CC, et al. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020. PMID: 32629122. doi:10.1016/j.cgh.2020.06.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。